Physician profile

Sean Patrick Whalen

Clinical Cardiac Electrophysiology · Nashville, TN

NPI 1124201298

$149,225.16

in general payments reported to CMS, 2019-2025

32 companies · $37K in 2025

The $37K reported for 2025 was more than what 93% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

See the full distribution for Clinical Cardiac Electrophysiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$43,313.00
Consulting Fee$16,375.00
Travel and Lodging$13,942.36
Food and Beverage$9,389.76

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $78,173.63 2019-2025 Farapulse, General - Therapies, Watchman Access System
Biosense Webster, INC. $19,859.96 2019-2025 Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter
Medtronic, INC. $12,374.39 2021-2025 Affera Mapping System, Cardioinsight, Pulseselect
Atricure, INC. $8,739.02 2019-2025 Epi-Sense Guided Coagulation System With Visitrax
Abbott Laboratories $8,406.09 2019-2025 Amplatzer Amulet, Ensite, Aveir
Biotronik INC. $8,149.53 2019-2025 Acticor 7 Vr-T Dx, Amvia Edge, Selectra
Philips North America LLC $6,205.95 2019-2024 (9274) Lld
Medical Device Business Services, INC. $5,175.00 2020-2021
Medtronic Vascular, INC. $275.07 2019-2020
Baylis Medical Company INC $262.50 2021
Janssen Pharmaceuticals, INC $259.79 2019-2023 Xarelto
Pfizer INC. $237.88 2022-2025
Edwards Lifesciences Corporation $186.20 2025 Evoque
Altathera Pharmaceuticals LLC $166.97 2023 Sotalol Hydrochloride
Amgen INC. $92.95 2019-2025 Repatha, Repatha
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Elutia, INC. $72.30 2021-2023
Ge Healthcare $69.57 2025
Irhythm Technologies, INC. $62.71 2019-2024 Zio Xt Patch, Zio Monitor
Impulse Dynamics (USA) INC. $59.61 2023-2024 Optimizer, Optimizer
E.R. Squibb & Sons, L.L.C. $55.54 2019-2025 Eliquis
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $52.56 2022-2025 Lifevest
Astrazeneca Pharmaceuticals LP $45.20 2022-2023 Farxiga
Actelion Pharmaceuticals US, INC. $43.38 2022-2023 Uptravi, Opsumit
Bayer Healthcare Pharmaceuticals INC. $38.84 2023
Sanofi-Aventis U.S. LLC $28.72 2019-2021
Cvrx, INC. $28.28 2019-2021
Zimmer Biomet Holdings, INC. $22.92 2022
Boehringer Ingelheim Pharmaceuticals, INC. $19.82 2022
Novartis Pharmaceuticals Corporation $17.52 2019
Vital Connect, INC $16.44 2025 Vitalpatch Rtm
Lexicon Pharmaceuticals, INC. $15.11 2024
Terumo Medical Corporation $11.71 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sean Patrick Whalen

$149,225.16

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $37K reported for 2025 was more than what 93% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/96823/sean-patrick-whalen

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.